Skip to content
Subscriber Only

Pfizer Vaccine Partner Warns Against Winner-Take-All Mentality

  • BioNTech CEO says drugmakers are working toward common goal
  • Pfizer, partner’s shares slide after Moderna vaccine data
Bloomberg business news
Moderna Vaccine Has 94.5% Efficacy, Trial Analysis Shows

The hunt for a Covid-19 vaccine isn’t a winner-take-all race but rather a challenge that will require more than one company to succeed, BioNTech SE’s Chief Executive Officer Ugur Sahin said.

Right now, producers aren’t competitors but rather are working with a common goal of immunizing as many people as possible next year, Sahin said in a panel hosted by Germany’s Sueddeutsche Zeitung newspaper on Monday. BioNTech is developing its shot together with Pfizer Inc.